Finance

Lists
Why is 002437 up 2.75%?
Dive Deeper
002437:SHE
Harbin Gloria Pharmaceuticals Co., Ltd.
CNÂ¥2.99
+2.75%
(+0.080) 1D
Nov 4, 3:04:36 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002437...
Open
CNÂ¥2.91
High
CNÂ¥2.99
Low
CNÂ¥2.88
Mkt. cap
6.49B
Avg. vol.
253.03M
Volume
173.97M
P/E ratio
17.31
52-wk high
CNÂ¥5.10
52-wk low
CNÂ¥2.37
EPS
CNÂ¥0.17
Shares outstanding
2.23B
No. of employees
2K
Open
CNÂ¥2.91
High
CNÂ¥2.99
Low
CNÂ¥2.88
Mkt. cap
6.49B
Avg. vol.
253.03M
Volume
173.97M
P/E ratio
17.31
52-wk high
CNÂ¥5.10
52-wk low
CNÂ¥2.37
EPS
CNÂ¥0.17
Shares outstanding
2.23B
No. of employees
2K
News stories
From web sources and news partners
About Harbin Gloria Pharmaceuticals Co., Ltd.
CEO-
Employees2.35K
FoundedMar 27, 2000
Headquarters-
SectorPharmaceutical industry
Industry-
Websitegloria.cc
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
470.45M
539.11M
467.96M
419.79M
Cost of goods sold
276.98M
293.39M
247.23M
219.91M
Cost of revenue
276.98M
293.39M
247.23M
219.91M
Research and development expenses
28.71M
11.57M
22.14M
22.02M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
130.82M
149.91M
112.39M
96.09M
Operating expense
163.43M
169.75M
142.51M
107.09M
Total operating expenses
440.41M
463.14M
389.74M
327.00M
Operating income
30.05M
75.96M
78.21M
92.79M
Other non operating income
990.79K
-1.24M
1.07M
-1.61M
EBT including unusual items
140.28M
107.13M
76.26M
96.43M
EBT excluding unusual items
166.50M
75.62M
77.67M
95.78M
Income tax expense
5.85M
10.46M
10.59M
7.04M
Effective tax rate
4.17%
9.77%
13.89%
7.31%
Other operating expenses
3.78M
8.23M
8.06M
-10.79M
Net income
133.14M
94.93M
64.06M
89.16M
Net profit margin
28.30%
17.61%
13.69%
21.24%
Earnings per share
-
-
-
-
Interest and investment income
137.90M
1.82M
1.80M
2.40M
Interest expense
-684.56K
-916.34K
-999.95K
-215.10K
Net interest expenses
137.21M
906.81K
802.42K
2.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
52.27M
98.18M
99.96M
115.01M
Gain or loss from assets sale
-3.54M
-
-12.52M
12.52M
Upcoming events
AI content may include mistakes. Learn more
Google apps